Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

Clinical trial NCT01644149 · COMPLETED

Trial details

NCT number: NCT01644149
Sponsor: PharmaJet, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza Prophylaxis

Start date: 2012-01-01
Primary completion: 2012-02-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.